Abbvie Inc (NYSE:ABBV) over-valued by 10%
| Website | https://www.abbvie.com/ |
| Sector | Healthcare |
| Industry | Drug Manufacturers General |
| Fiscal Year End | Dec 31, 2021 |
| Market Cap | $204,616,581,120 |
| Beta | 0.805347 |
| Average Volume | $6,960,860 |
| Last Dividend | 4.96% |
| Price on May 6, 2022 | $154.14 |
| Autochartist™ Valuation | $138.07 |
| Conclusion |
10% over-valued |
| Download Report |
